Patent 12084467 was granted and assigned to Gilead Sciences on September, 2024 by the United States Patent and Trademark Office.
The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.